| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-28 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.38 | 6e-26 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |